Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteases

References

Abdel-Rahman, H.M., Al-Karamany, G.S., El-Koussi, N.A., Youssef, A.F., and Kiso, Y. (2002). HIV protease inhibitors: peptidomimetic drugs and future perspectives. Curr. Med. Chem.9, 1905–1922.10.2174/0929867023368890Suche in Google Scholar

Boss, C., Richard-Bildstein, S., Weller, T., Fischli, W., Meyerm S., and Binkert, C. (2003). Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents. Curr. Med. Chem.10, 883–907.10.2174/0929867033457674Suche in Google Scholar

Coombs, G.H., Goldberg, D.E., Klemba, M., Berry, C., Kay, J., and Mottram, J. (2001). Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends Parasitol.17, 532–537.10.1016/S1471-4922(01)02037-2Suche in Google Scholar

Hamada, Y., and Kiso, Y. (2003). Protease inhibitors: design and new features. Kagaku To Seibutsu41, 796–803.10.1271/kagakutoseibutsu1962.41.796Suche in Google Scholar

Kimura, T., Hidaka, K., Abdel-Rahman, H.M., Matsumoto, H., Tanaka, Y., Matsui, Y., Hayashi, Y., and Kiso, Y. (2004). Design and synthesis of dipeptide-type HIV-1 protease inhibitors with high antiviral activity. In: Peptide Science 2003, M. Ueki, ed. (Osaka, Japan: The Japanese Peptide Society), pp. 241–244.Suche in Google Scholar

Kiso, A., Hidaka, K., Tsuchiya, Y., Kimura, T., Hayashi, Y., Nezami, A., Liu, J., Goldberg, D.E., Freire, E., and Kiso, Y. (2004a). Dipeptide-type inhibitors targeting plasmepsins from Plasmodium faliciparum. In: Peptide Science 2003, M. Ueki, ed. (Osaka, Japan: The Japanese Peptide Society), pp. 235–238.Suche in Google Scholar

Kiso, A., Hidaka, K., Kimura, T., Hayashi, Y., Nezami, A., Freire, E., and Kiso, Y. (2004b). Search for substrate-based inhibitors fitting the S2′ space of malarial aspartic protease plasmepsin II. J. Peptide Sci., in press.10.1002/psc.609Suche in Google Scholar

Kiso, Y. (1996). Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere. Biopolymers40, 235–244.10.1002/(SICI)1097-0282(1996)40:2<235::AID-BIP3>3.0.CO;2-XSuche in Google Scholar

Kiso, Y., Matsumoto, H., Mizumoto, S., Kimura, T., Fujiwara, Y., and Akaji, K. (1999). Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic. Biopolymers51, 59–68.10.1002/(SICI)1097-0282(1999)51:1<59::AID-BIP7>3.0.CO;2-3Suche in Google Scholar

Macchi, B., Balestrieri, E., and Mastino, A. (2003). Effect of nucleoside-based antiretroviral chemotherapy on human T cell leukemia/lymphotropic virus type 1 (HTLV-I) infection in vitro. J. Antimicrob. Chemother.51, 1327–1330.10.1093/jac/dkg240Suche in Google Scholar

Maegawa, H., Kimura, T., Arii, Y., Matsui, Y., Hayashi, Y., and Kiso, Y. (2002). Identification of peptidomimetic HTLV-I protease inhibitors containing allophenylnorstatine as a transition-state isostere. In: Peptides 2002, E. Benedetti and C. Pedone, eds. (Naples, Italy: Edizioni Ziino), pp. 548–549.Suche in Google Scholar

Maegawa, H., Kimura, T., Arii, Y., Matsui, Y., Kasai, S., Hayashi, Y., and Kiso, Y. (2004). Identification of peptidomimetic HTLV-I protease inhibitors containing allophenylnorstatine as the transition-state mimic. Bioorg. Med. Chem. Lett., in press.10.1016/j.bmcl.2004.09.034Suche in Google Scholar

Mimoto, T., Kato, R., Takaku, H., Nojima, S., Terashima, K., Misawa, S., Kukazawa, T., Ueno, T., Sato, H., Shintani, M., Kiso, Y., and Hayashi, H. (1999). Structure-activity relationship on small-sized HIV protease inhibitors containing allophenylnorstatine. J. Med. Chem.42, 1789–1802.10.1021/jm980637hSuche in Google Scholar

Mimoto, T., Terashima, K., Nojima, S., Takaku, H., Nakayama, M., Shintani, M., Yamaoka, T., and Hayashi, H. (2004). Structure-activity and structure-metabolism relationships of HIV protease inhibitors containing the 3-hydroxy-2-methylbenzoyl-allophenylnorstatine structure. Bioorg. Med. Chem.12, 281–293.10.1016/j.bmc.2003.10.037Suche in Google Scholar

Nezami, A., Laque, I., Kimura, T., Kiso, Y., and Freire, E. (2002). Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target. Biochemistry41, 2273–2280.10.1021/bi0117549Suche in Google Scholar

Nezami, A., Kimura, T., Hidaka, K., Kiso., A., Liu, J., Kiso, Y., Goldberg, D.E., and Freire, E. (2003). High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor. Biochemistry42, 8459–8464.10.1021/bi034131zSuche in Google Scholar

Reiling, K.K., Endres, N.F., Dauber, D.S., Craik, C.S., and Stroud, R.M. (2002). Anisotropic dynamics of the JE-2147-HIV protease complex: drug resistance and thermodynamic binding mode examined in a 1.09 Å structure. Biochemistry41, 4582–4594.10.1021/bi011781zSuche in Google Scholar

Shuker, S.B., Mariani, V.L., Herger, B.E., and Danisson, K.J. (2003). Understanding HTLV-1 protease. Chem. Biol.10, 373–380.10.1016/S1074-5521(03)00104-2Suche in Google Scholar

UNAIDS and World Health Organization Report (2003). http://www.unaids.org.Suche in Google Scholar

Vega, S., Kang, L.-W., Velazquez-Campoy, A., Kiso, Y., Amzel, L.M., and Freire, E. (2004). A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 protease. Proteins Struct. Funct. Bioinformatics55, 594–602.10.1002/prot.20069Suche in Google Scholar PubMed

Velazquez-Campoy, A., Kiso, Y., and Freire, E. (2001). The binding energetics of first and second-generation HIV-1 protease inhibitors: implications for drug design. Arch. Biochem. Biophys.390, 169–175.10.1006/abbi.2001.2333Suche in Google Scholar PubMed

Yoshimura, K., Kato, R., Yusa, K., Kavlick, M.F., Maroun, V., Nguyen, A., Mimoto, T., Ueno, T., Shintani, M., Falloon, J., et al. (1999). JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1. Proc. Natl. Acad. Sci. USA96, 8675–8680.10.1073/pnas.96.15.8675Suche in Google Scholar PubMed PubMed Central